MedPath

Strategies for Inflammation and Cardiovascular Disease (CVD) Prevention

Not Applicable
Completed
Conditions
Atherosclerosis
Diabetes
Interventions
Behavioral: Mindfulness-based stress reduction
Behavioral: Nutrition Enhancement
Registration Number
NCT02165228
Lead Sponsor
Montana State University
Brief Summary

The long-term goal of the proposed research is to identify and develop effective interventions to decrease persistent, low-level inflammation and risk of CVD. Stress is a substantial contributor to inflammation, and interactions among stress, inflammation, body mass index, and health behaviors have been measured. Mindfulness-based stress reduction (MBSR) is effective for stress reduction, has been shown to be effective for inflammation reduction in individuals with disease, and is a sustainable practice for individuals across the health spectrum. Diet strategies are an effective means of reducing inflammation for some individuals, but may not be successful for many people, as evidenced by the steady rise in obesity rates. The specific aims of this study are to 1) test the effectiveness of MBSR compared to an established intervention of a nutrition enhancement (NE) intervention for the reduction of inflammation, and 2) test the effectiveness of MBSR compared to a non-intervention control conditions (CON) for the reduction of inflammation. Men and women 25-45 years of age will be randomly assigned to participate in MBSR (n=60) or DIET (n=60) or CON (n=60) interventions for 16 weeks. Serum CRP concentrations, additional inflammatory cytokines (tumor necrosis factor-a, interleukin-6), cortisol diurnal profiles, anthropometrics, dietary intake, and all components of the metabolic syndrome will be measured pre- and post-intervention to elucidate underlying mechanisms and to determine whether health benefits beyond inflammation reduction occur.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
108
Inclusion Criteria
  • Elevated waist circumference or BMI
Exclusion Criteria
  • Participation in calorie restricted diet in previous 30 d
  • Participation in stress reduction program in previous 30 d
  • Take blood pressure, lipid lowering or anti-inflammatory medications
  • Hypertension
  • Diabetes
  • Heart disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mindfulness-based stress reductionMindfulness-based stress reductionStress reduction class and behavioral intervention
Nutrition EnhancementNutrition EnhancementNutrition education class and behavioral intervention
Primary Outcome Measures
NameTimeMethod
Inflammation Biomarkers16 weeks

C-reactive protein (CRP), tumor necrosis factor-alpha, interleukin-6

Metabolic Syndrome Extent16 weeks

Blood pressure, waist circumference, fasting glucose, fasting HDL, fasting triglycerides, number of components

Secondary Outcome Measures
NameTimeMethod
Waist to hip ratio16 weeks

Circumference of the waist/circumference of the hips

Cholesterol16 weeks

Fasting total cholesterol concentration

Insulin Resistance16 weeks

Fasting insulin concentration and homeostatic model assessment of insulin resistance (HOMA-IR)

Stress hormone levels16 weeks

Salivary cortisol concentration at 7 a.m., 12 and 4 p.m.

Perceived Stress16 weeks

Score from the perceived stress scale.

Depression16 weeks

Depression Score

BMI16 weeks

BMI = weight/height squared

Mindfulness16 weeks

Perception of mindfulness from subscale within the self-compassion scale questionnaire

Trial Locations

Locations (1)

Montana State University

🇺🇸

Bozeman, Montana, United States

© Copyright 2025. All Rights Reserved by MedPath